Advertisement

Topics

Judge Reverses Another J&J Talc Verdict

07:53 EDT 2 Nov 2017 | CHEManager

A court in the US state of California has reversed a verdict against drugmaker Johnson & Johnson in the ongoing litigation over whether the company’s talc productions can be linked to cancer. The judgment just announced reverses an award of $417 million on behalf of a woman who argued that routine use of the company’s talc product in intimate applications caused her ovarian cancer. The court has ordered a new trial.

Original Article: Judge Reverses Another J&J Talc Verdict

NEXT ARTICLE

More From BioPortfolio on "Judge Reverses Another J&J Talc Verdict"

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topics

Biotechnology Business
Alliances Astrazeneca Bioethics Boehringer Clinical Research Organization Collaborations GSK Johnson & Johnson Lilly Merck Mergers and Acquisitions Nexium Novartis Pfizer Roche Sanofi ...

Cancer
  Bladder Cancer Brain Cancer Breast Cancer Cancer Cervical Cancer Colorectal Head & Neck Cancers Hodgkin Lymphoma Leukemia Lung Cancer Melanoma Myeloma Ovarian Cancer Pancreatic Cancer ...